This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Big Acquirers of 2011

NEW YORK ( TheStreet) -- 2011 saw renewed corporate merger and acquisition activity across various industry sectors. Investors might want to take a look at the companies resulting from these deals, because the merged companies may wind up with more efficiency or industry heft.

The following stocks either completed or announced acquisitions during the past year.

They are listed in descending order of total deal value.

1. Express Scripts (ESRX - Get Report) is one of the largest pharmacy benefit management companies in North America. It provides network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation and other services.

In July, the company announced it would acquire all of Medco Health Solutions' (MHS) shares in a cash and stock deal.

Under the agreement, Medco's shareholders will receive $28.80 in cash and 0.81 shares of Express Scripts for each Medco share they own. Based on recent stock prices, the purchase price is valued at $25.2 billion, a premium to Medco's recent market capitalization of $21.6 billion.

The deal is expected to generate synergies of $1 billion once fully integrated, representing 1% of the combined costs. The transaction is expected to be slightly accretive to EPS in the first year after closing and moderately accretive when fully integrated. The deal is likely to close during the first half of 2012, subject to regulatory approval.

Of the 26 analysts covering Express Scripts, 88% rate the stock a buy. Analysts polled by Bloomberg on average expect the stock to gain 26.5% to $56.79 in the coming 12 months.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player
1 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
TXN $56.64 0.37%
ANR $0.04 3.17%
ECL $115.04 -0.23%
DHR $96.11 0.21%
ESRX $72.95 0.29%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs